CompoAtlas

PFW Qing Re Ling 350mg Capsule

PFW Qing Re Ling 350mg Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Chrysanthemum indicumChrysanthemum indicum[42MG ]Not identified
SALVIAE MILTIORRHIZAE RADIXSALVIAE MILTIORRHIZAE RADIX[28MG ]Not identified
RADIX SCUTELIARIAERADIX SCUTELIARIAE[17MG ]Not identified
RADIX SCROPHULARIAERADIX SCROPHULARIAE[28MG]Not identified
RADIX REHMANNIAERADIX REHMANNIAE[35MG ]Not identified
RADIX PAEONIAE RUBRARADIX PAEONIAE RUBRA[28MG ]Not identified
LONICERA JAPONICA THUNB FLOSLONICERA JAPONICA THUNB FLOS[42MG ]Not identified
HERBA TARAXACI/TARAXACUM MONGOLICUMHERBA TARAXACI/TARAXACUM MONGOLICUM[42MG ]Not identified
HERBA HEDYOTIS DIFFUSAEHERBA HEDYOTIS DIFFUSAE[33MG]Not identified
FRUCTUS GARDENIAEFRUCTUS GARDENIAE[20MG]Not identified
CORTEX MOUTAN RADICISCORTEX MOUTAN RADICIS[35MG ]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL19986893T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
WHITE HERON PHARMACEUTICAL SDN. BHD.
Manufacturer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Registration period starting
2023-12-28
Published validity end
2028-12-28

Original register data

View published fields and their variants
Active ingredients
Chrysanthemum indicum[42MG ],SALVIAE MILTIORRHIZAE RADIX[28MG ],RADIX SCUTELIARIAE[17MG ],RADIX SCROPHULARIAE[28MG],RADIX REHMANNIAE[35MG ],RADIX PAEONIAE RUBRA[28MG ],LONICERA JAPONICA THUNB FLOS[42MG ],HERBA TARAXACI/TARAXACUM MONGOLICUM[42MG ],HERBA HEDYOTIS DIFFUSAE[33MG],FRUCTUS GARDENIAE[20MG],CORTEX MOUTAN RADICIS[35MG ]
Valid until
2028-12-28
Registration date
2023-12-28
Published description
NATURAL PRODUCT
Licence holder
WHITE HERON PHARMACEUTICAL SDN. BHD.
Producer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Published name
PFW Qing Re Ling 350mg Capsule
Published reference
1995084642T
Registration number
MAL19986893T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL19986893T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PFW Qing Re Ling 350mg Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL19986893T-pfw-qing-re-ling-350mg-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line